AK Medical executes HKD 1.40 million share buyback; cumulative repurchases hit 4.46 million shares

Bulletin Express

Apr 15

AK Medical Holdings Limited disclosed a Next Day Return confirming the purchase of 200,000 ordinary shares on 15 April 2026 at HKD 7.00 per share, for a total consideration of HKD 1.40 million.

The latest transaction lifts total buybacks under the 18 June 2025 general mandate to 4.46 million shares, equivalent to 3.97 % of the company’s issued share capital on the mandate date. All repurchased shares are earmarked for cancellation, though the 1.12 billion issued share count remains unchanged pending formal cancellation.

The mandate authorises AK Medical to repurchase up to 112.27 million shares, leaving roughly 107.81 million shares—about 96 % of the mandate—still available. A 30-day moratorium on new share issues runs through 15 May 2026.

Recent buyback activity (all for cancellation, not yet removed from the register): • 06 Feb 2026: 640,000 shares at a volume-weighted average price of HKD 5.92 • 13 Feb 2026: 1.09 million shares at HKD 6.21 • 16 Feb 2026: 1.14 million shares at HKD 6.18 • 26 Mar 2026: 1.19 million shares at HKD 6.02 • 01 Apr 2026: 100,000 shares at HKD 6.34 • 02 Apr 2026: 100,000 shares at HKD 6.40 • 15 Apr 2026: 200,000 shares at HKD 7.00

Post-transaction, the official issued share capital is unchanged at 1,123.92 million shares, with all regulatory confirmations submitted by the company secretary, Ma Rongkun.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1165912961"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1165912961\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1165912961?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-15 18:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165912961","market":"us","top_or_hot":-1,"title":"AK Medical executes HKD 1.40 million share buyback; cumulative repurchases hit 4.46 million shares","media":"Bulletin Express","content":"<p>AK Medical Holdings Limited disclosed a Next Day Return confirming the purchase of 200,000 ordinary shares on 15 April 2026 at HKD 7.00 per share, for a total consideration of HKD 1.40 million.</p>\n<p>The latest transaction lifts total buybacks under the 18 June 2025 general mandate to 4.46 million shares, equivalent to 3.97 % of the company’s issued share capital on the mandate date. All repurchased shares are earmarked for cancellation, though the 1.12 billion issued share count remains unchanged pending formal cancellation.</p>\n<p>The mandate authorises AK Medical to repurchase up to 112.27 million shares, leaving roughly 107.81 million shares—about 96 % of the mandate—still available. A 30-day moratorium on new share issues runs through 15 May 2026.</p>\n<p>Recent buyback activity (all for cancellation, not yet removed from the register):  \n• 06 Feb 2026: 640,000 shares at a volume-weighted average price of HKD 5.92  \n• 13 Feb 2026: 1.09 million shares at HKD 6.21  \n• 16 Feb 2026: 1.14 million shares at HKD 6.18  \n• 26 Mar 2026: 1.19 million shares at HKD 6.02  \n• 01 Apr 2026: 100,000 shares at HKD 6.34  \n• 02 Apr 2026: 100,000 shares at HKD 6.40  \n• 15 Apr 2026: 200,000 shares at HKD 7.00</p>\n<p>Post-transaction, the official issued share capital is unchanged at 1,123.92 million shares, with all regulatory confirmations submitted by the company secretary, Ma Rongkun.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AK Medical executes HKD 1.40 million share buyback; cumulative repurchases hit 4.46 million shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAK Medical executes HKD 1.40 million share buyback; cumulative repurchases hit 4.46 million shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-15 18:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AK Medical Holdings Limited disclosed a Next Day Return confirming the purchase of 200,000 ordinary shares on 15 April 2026 at HKD 7.00 per share, for a total consideration of HKD 1.40 million.</p>\n<p>The latest transaction lifts total buybacks under the 18 June 2025 general mandate to 4.46 million shares, equivalent to 3.97 % of the company’s issued share capital on the mandate date. All repurchased shares are earmarked for cancellation, though the 1.12 billion issued share count remains unchanged pending formal cancellation.</p>\n<p>The mandate authorises AK Medical to repurchase up to 112.27 million shares, leaving roughly 107.81 million shares—about 96 % of the mandate—still available. A 30-day moratorium on new share issues runs through 15 May 2026.</p>\n<p>Recent buyback activity (all for cancellation, not yet removed from the register):  \n• 06 Feb 2026: 640,000 shares at a volume-weighted average price of HKD 5.92  \n• 13 Feb 2026: 1.09 million shares at HKD 6.21  \n• 16 Feb 2026: 1.14 million shares at HKD 6.18  \n• 26 Mar 2026: 1.19 million shares at HKD 6.02  \n• 01 Apr 2026: 100,000 shares at HKD 6.34  \n• 02 Apr 2026: 100,000 shares at HKD 6.40  \n• 15 Apr 2026: 200,000 shares at HKD 7.00</p>\n<p>Post-transaction, the official issued share capital is unchanged at 1,123.92 million shares, with all regulatory confirmations submitted by the company secretary, Ma Rongkun.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01789","symbol_name":"爱康医疗","start_time":0,"source_url":"","article_id":"1165912961","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165912961","pubTimestamp":1776249837,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"AK Medical Holdings Limited disclosed a Next Day Return confirming the purchase of 200,000 ordinary shares on 15 April 2026 at HKD 7.00 per share, for a total consideration of HKD 1.40 million. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01789":"爱康医疗"},"translate_title":"爱康医疗执行140万港元股份回购；累计回购达446万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01789":1},"content_text":"AK Medical Holdings Limited disclosed a Next Day Return confirming the purchase of 200,000 ordinary shares on 15 April 2026 at HKD 7.00 per share, for a total consideration of HKD 1.40 million.\nThe latest transaction lifts total buybacks under the 18 June 2025 general mandate to 4.46 million shares, equivalent to 3.97 % of the company’s issued share capital on the mandate date. All repurchased shares are earmarked for cancellation, though the 1.12 billion issued share count remains unchanged pending formal cancellation.\nThe mandate authorises AK Medical to repurchase up to 112.27 million shares, leaving roughly 107.81 million shares—about 96 % of the mandate—still available. A 30-day moratorium on new share issues runs through 15 May 2026.\nRecent buyback activity (all for cancellation, not yet removed from the register):  \n• 06 Feb 2026: 640,000 shares at a volume-weighted average price of HKD 5.92  \n• 13 Feb 2026: 1.09 million shares at HKD 6.21  \n• 16 Feb 2026: 1.14 million shares at HKD 6.18  \n• 26 Mar 2026: 1.19 million shares at HKD 6.02  \n• 01 Apr 2026: 100,000 shares at HKD 6.34  \n• 02 Apr 2026: 100,000 shares at HKD 6.40  \n• 15 Apr 2026: 200,000 shares at HKD 7.00\nPost-transaction, the official issued share capital is unchanged at 1,123.92 million shares, with all regulatory confirmations submitted by the company secretary, Ma Rongkun.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}